Form 4 holding
Director
BIOMARIN PHARMACEUTICAL INC
- Security class
- Common Stock
- Shares / value
- 31,299
- Estimated value
- $2,623,169
- Report date
- 18 Mar 2024
- Price
- $83.81
- Ownership
- Direct
Dennis Slamon
Insider Reports History
- Location
- San Rafael, CA
- Reporting signature
- /s/ Tae Sang Yoo, Attorney-in-Fact
- Transaction evidence
- Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
SEC record
SEC evidence
Holdings reported by Dennis Slamon:
Form 4 holding
Director
BIOMARIN PHARMACEUTICAL INC
- Security class
- Stock Option (Right to Buy Common Stock)
- Shares / value
- 0
- Estimated value
- Report date
- 18 Mar 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Dennis Slamon
4
BMRN
BIOMARIN PHARMACEUTICAL INC
- Report period
- 18 Mar 2024
- Transactions
- 3
- Transaction value
- -$33.1
- Filing time
- 20 Mar 2024, 17:13
- Role
- Director
- Next action
- Open filing details
4
BMRN
BIOMARIN PHARMACEUTICAL INC
- Report period
- 23 May 2023
- Transactions
- 1
- Transaction value
- $0
- Filing time
- 24 May 2023, 18:29
- Role
- Director
- Next action
- Open filing details
4
BMRN
BIOMARIN PHARMACEUTICAL INC
- Report period
- 24 May 2022
- Transactions
- 1
- Transaction value
- $0
- Filing time
- 26 May 2022, 21:42
- Role
- Director
- Next action
- Open filing details
4
BMRN
BIOMARIN PHARMACEUTICAL INC
- Report period
- 28 Feb 2022
- Transactions
- 6
- Transaction value
- -$501,013
- Filing time
- 02 Mar 2022, 15:57
- Role
- Director
- Next action
- Open filing details
4
BMRN
BIOMARIN PHARMACEUTICAL INC
- Report period
- 25 May 2021
- Transactions
- 1
- Transaction value
- $0
- Filing time
- 27 May 2021, 20:44
- Role
- Director
- Next action
- Open filing details